Javier Fernández‐Ruíz

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease

Isabel Lastres‐Becker, Francisco Molina‐Holgado, J.A. Ramos et al. · Neurobiology of Disease · 2005 · 410 citations · Full text

Life Sciences, Neuroscience, Pharmacology +12

Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity

Javier Palazuelos, Tania Aguado, M. Ruth Pazos et al. · Brain · 2009 · 379 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Parkinson Phenotype in Aged PINK1-Deficient Mice Is Accompanied by Progressive Mitochondrial Dysfunction in Absence of Neurodegeneration

Suzana Gispert, Filomena Ricciardi, Alexander Kurz et al. · PLoS ONE · 2009 · 375 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Pharmacological Targeting of the Transcription Factor Nrf2 at the Basal Ganglia Provides Disease Modifying Therapy for Experimental Parkinsonism

Agnieszka Jaźwa, Ana I. Rojo, Nadia G. Innamorato et al. · Antioxidants and Redox Signaling · 2011 · 325 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties

Moisés Garcı́a-Arencibia, Sara González, Eva de Lago et al. · Brain Research · 2006 · 319 citations

Life Sciences, Neuroscience, Pharmacology +15